Departing FDA Commissioner Dr. Scott Gottlieb is returning to the conservative think tank American Enterprise Institute to focus on solutions to drug pricing issues, according to a report from The Hill.
Gottlieb will serve as a resident fellow at the Washington-based group, spending six days a month at its facilities in Washington D.C., according to the report.
“My colleagues and I am thrilled that [Gottlieb] is coming home to AEI. It will be wonderful to have him back at the lunch table. And we will benefit so much from AEI being his intellectual home. I’m excited for the work he will be doing,” AEI resident scholar Michael Strain tweeted, according to The Hill report.
While at AEI, Gottlieb will focus on “market failures” that keep drug prices high, according to a Washington Post report.
He also said that he plans to write bout FDA-related issues, but would be doing so carefully, according to the report.
“I don’t want to be on the sidelines causing grief for [Ned Sharpless],” Gottlieb told The Post. Sharpless was tapped to serve as interim head after Gottlieb’s departure.